STOCK TITAN

Pluri (NASDAQ: PLUR) regains key Nasdaq listing standard compliance

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Pluri Inc. reports it has regained compliance with Nasdaq’s market value listing standard. Nasdaq notified the company that, for 10 consecutive business days from February 13, 2026 to February 26, 2026, the market value of Pluri’s listed securities was at least $35 million, meeting Listing Rule 5550(b)(2).

Because this requirement is now satisfied, Nasdaq has closed the deficiency matter and Pluri’s shares remain in good standing on The Nasdaq Capital Market. Earlier, Nasdaq had warned Pluri that it did not meet the required market value or the alternative stockholders’ equity or net income standards.

Positive

  • Nasdaq compliance restored: Pluri regained compliance with Nasdaq Listing Rule 5550(b)(2) after its market value of listed securities reached at least $35 million for 10 consecutive business days, closing the deficiency matter and keeping the company in good standing on The Nasdaq Capital Market.

Negative

  • None.

Insights

Pluri has cleared a Nasdaq listing compliance issue by meeting the $35 million market value test.

Nasdaq had previously flagged Pluri Inc. for failing to meet Listing Rule 5550(b)(2), which requires a market value of listed securities of at least $35 million, or satisfying alternative equity or net income standards for continued listing on The Nasdaq Capital Market.

Nasdaq’s new letter confirms that, for 10 consecutive business days from February 13, 2026 to February 26, 2026, Pluri’s market value of listed securities was at or above $35 million. This restores compliance and removes the immediate risk associated with that deficiency notice.

The matter is now closed and Pluri remains in good standing on The Nasdaq Capital Market. Future disclosures in periodic reports can show whether the company continues to meet this market value or the alternative listing standards over time.

false 0001158780 0001158780 2026-02-27 2026-02-27 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC  20549

 

FORM 8-K

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of report (Date of earliest event reported): March 2, 2026 (February 27, 2026)

 

PLURI INC.

(Exact Name of Registrant as Specified in Its Charter)

 

Nevada   001-31392   98-0351734
(State or Other Jurisdiction
of Incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

MATAM Advanced Technology Park    
Building No. 5    
Haifa, Israel   3508409
(Address of Principal Executive Offices)   (Zip Code)

 

011 972 74 710 7171

(Registrant’s telephone number, including area code)

 

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Shares, par value $0.00001 per share   PLUR   The Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 8.01Other Events.

 

As previously reported, on January 20, 2026, Pluri Inc. (the “Company”) received a deficiency letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”), notifying the Company that it was not in compliance with Nasdaq Listing Rule 5550(b)(2), which requires the Company to maintain a minimum of $35 million in market value of listed securities for continued listing on The Nasdaq Capital Market, nor was it in compliance with either of the alternative listing standards, including having stockholders’ equity of at least $2.5 million or net income of $500,000 from continuing operations in the most recently completed fiscal year, or in two of the three most recently completed fiscal years.

 

On February 27, 2026, the Company received a letter from Nasdaq, determining that the Company has regained compliance with Listing Rule 5550(b)(2), due to the fact that for the 10 consecutive business days from February 13, 2026 to February 26, 2026, the market value of the Company’s listed securities was $35 million or greater, satisfying the requirement under Rule 5550(b)(2). As a result, this matter is now closed, and the Company remains in good standing on The Nasdaq Capital Market.

 

1

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  PLURI INC.
   
Date: March 2, 2026 By: /s/ Liat Zalts
  Name:  Liat Zalts
  Title: Chief Financial Officer

 

2

 

FAQ

What did Pluri Inc. (PLUR) announce regarding its Nasdaq listing status?

Pluri Inc. announced that it has regained compliance with a key Nasdaq listing standard. Nasdaq confirmed that Pluri now meets the market value of listed securities requirement, so the previous deficiency notice has been closed and the company remains listed on The Nasdaq Capital Market.

Which Nasdaq rule did Pluri Inc. (PLUR) regain compliance with?

Pluri regained compliance with Nasdaq Listing Rule 5550(b)(2). This rule requires a minimum market value of listed securities of $35 million for continued listing on The Nasdaq Capital Market, or satisfaction of alternative stockholders’ equity or net income standards as specified in the rule.

How did Pluri Inc. (PLUR) regain compliance with Nasdaq’s market value requirement?

Pluri regained compliance by maintaining sufficient market value over a 10-day period. From February 13, 2026 to February 26, 2026, the market value of Pluri’s listed securities was at least $35 million for 10 consecutive business days, satisfying Nasdaq Listing Rule 5550(b)(2).

What prior Nasdaq deficiency did Pluri Inc. (PLUR) face before this update?

Pluri previously received a Nasdaq deficiency letter on January 20, 2026. The notice stated the company did not comply with Rule 5550(b)(2) and also did not meet alternative standards for minimum stockholders’ equity or net income required for ongoing listing on The Nasdaq Capital Market.

Does Pluri Inc. (PLUR) remain in good standing on The Nasdaq Capital Market?

Yes, Pluri remains in good standing on The Nasdaq Capital Market. After confirming Pluri’s market value of listed securities met the $35 million threshold for 10 consecutive business days, Nasdaq closed the deficiency matter and kept the company’s listing status active.

What minimum market value does Nasdaq require under Rule 5550(b)(2)?

Nasdaq Listing Rule 5550(b)(2) requires a minimum $35 million market value of listed securities. Companies on The Nasdaq Capital Market can also satisfy continued listing through alternative tests involving minimum stockholders’ equity or specified levels of net income from continuing operations.

Filing Exhibits & Attachments

3 documents
Pluri Inc

NASDAQ:PLUR

PLUR Rankings

PLUR Latest News

PLUR Latest SEC Filings

PLUR Stock Data

36.18M
5.72M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
Israel
HAIFA